CHOP Plus Rituximab (CHOP-R) in Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) or CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT).
Phase of Trial: Phase II
Latest Information Update: 05 Oct 2016
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Vincristine
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 10 Aug 2016 Status changed from recruiting to completed.
- 02 Feb 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 10 Jul 2007 Status changed from in progress to initiated.